Skip to content
Modalert
Active ingredient: Modafinil

Modalert

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from $ 376.00, free express delivery from $ 564.00

Secure Payments
Track your order
Best price guarantee

It is intended for adults whose alertness problem has been medically assessed, not for ordinary tiredness or general productivity. By affecting several brain signalling pathways, including dopamine, it supports wakefulness.

Overview

Modalert contains modafinil, a wakefulness-promoting medicine used mainly for narcolepsy and excessive daytime sleepiness linked to obstructive sleep apnoea or shift-work sleep disorder. It is intended for adults whose alertness problem has been medically assessed, not for ordinary tiredness or general productivity. Modafinil affects several brain signalling pathways, including dopamine, to support wakefulness.

Formulation

Modalert tablets contain modafinil, a wakefulness-promoting agent also described as a eugeroic. The term means a medicine that promotes alertness rather than producing the broad pattern of stimulation associated with traditional amphetamine medicines.

Its established clinical uses include:

  • Narcolepsy with excessive daytime sleepiness or sudden sleep attacks.
  • Persistent daytime drowsiness associated with obstructive sleep apnoea, alongside treatment for the airway problem.
  • Shift-work sleep disorder when sleepiness occurs during required night or rotating shifts.
  • Selected specialist uses where a prescriber has assessed the expected benefit and risks.

Modalert can reduce sleepiness, but it does not remove the airway obstruction that causes obstructive sleep apnoea. Continuous positive airway pressure, weight management where appropriate, sleep scheduling, and other treatment measures remain relevant to the underlying condition. Medsafe and other medicines regulators treat modafinil as a prescription medicine requiring clinical assessment [1]. NICE also publishes guidance relevant to the assessment and management of sleep disorders.

A useful distinction is alertness versus energy: Modalert may reduce pathological sleepiness, but it does not replace sufficient sleep, regular meals, or treatment for an untreated sleep disorder.

The product belongs to the wakefulness-promoting and stimulant-related medicine group. Its clinical role is narrower than the way the word stimulant is used in everyday conversation.

The amount per intake is set individually for each person rather than being one fixed number.

Therapeutic indications

Its established clinical uses include:

  • Narcolepsy with excessive daytime sleepiness or sudden sleep attacks.
  • Persistent daytime drowsiness associated with obstructive sleep apnoea, alongside treatment for the airway problem.
  • Shift-work sleep disorder when sleepiness occurs during required night or rotating shifts.
  • Selected specialist uses where a prescriber has assessed the expected benefit and risks.

Dosage and administration

The prescribed amount per intake is individualised. Follow the clinician’s specific schedule for the indication being treated.

  • Take the prescribed tablet by mouth at the recommended time.
  • For daytime sleepiness, the dose is commonly scheduled early enough to support daytime wakefulness without unnecessarily delaying night-time sleep.
  • For shift-work sleep disorder, timing is linked to the work shift and should be set by the prescriber.
  • Do not increase the amount because sleepiness has not improved immediately.
  • Do not take two doses together after a missed dose.
  • If a missed dose is remembered close to the usual sleep period, taking it late may cause insomnia; obtain individual instructions for the next dose.
  • Modalert does not replace planned sleep or continuous positive airway pressure for obstructive sleep apnoea.

Dosing differs between narcolepsy, obstructive sleep apnoea-related sleepiness, and shift-work sleep disorder. Liver impairment, older age, psychiatric history, blood pressure, and interacting medicines may alter the regimen.

A missed dose should not be “made up” by doubling the next intake. The safest action depends on the indication and time remaining before sleep, so the prescriber or pharmacist should provide a plan suited to the individual regimen.

Reasons not to use it

  • Serious allergic reaction to modafinil or a related medicine.
  • Significant cardiovascular disease.
  • Uncontrolled blood pressure.
  • Liver impairment.
  • History of psychosis, mania, severe anxiety, or serious mood instability.
  • Concomitant use of another modafinil or armodafinil product, stimulant medicine, or supplement marketed for stimulation without medical advice.
  • Hormonal contraceptives require clinical review because modafinil may reduce their reliability.
  • Anticoagulants such as warfarin require medical review because monitoring may be required.

When this is not for you

Modalert is not for you if you have had a serious allergic reaction to modafinil or a related medicine. It also requires careful assessment if you have significant cardiovascular disease, uncontrolled blood pressure, liver impairment, a history of psychosis, mania, severe anxiety, or serious mood instability.

Pregnancy and breastfeeding require a separate risk assessment. Modafinil may reduce the reliability of hormonal contraception, including some oral contraceptives, implants, injections, and other hormonal methods. This effect can continue for a period after treatment stops, so contraceptive planning should be discussed before starting or changing treatment.

Possible side effects

Reported side effects of modafinil include headache, nausea, diarrhoea, back pain, anxiety, nervousness, dizziness, a stuffy nose, upset stomach, trouble sleeping, and blurred vision. The likelihood varies between people and may change with the strength, timing, duration, and other medicines.

Common or bothersome effects

  • Headache.
  • Nausea or upset stomach.
  • Diarrhoea.
  • Back pain.
  • Anxiety or nervousness.
  • Dizziness.
  • Nasal congestion.
  • Trouble sleeping.
  • Blurred vision.

Taking a dose later than planned can worsen insomnia. Nausea may be more noticeable when a person takes the tablet without a suitable meal pattern, although the prescribed timing should remain the priority. Persistent or troublesome effects warrant review rather than self-adjustment.

Dizziness and blurred vision can make driving, cycling, ladder work, and machinery use unsafe. Wait until vision and balance are normal before performing these activities.

Symptoms requiring prompt clinical assessment

Contact a clinician promptly if there is persistent blurred vision, marked anxiety, a sustained rise in blood pressure, chest discomfort, palpitations, severe insomnia, or a major change in mood or behaviour.

Urgent warning signs

Stop and seek urgent medical help for a spreading rash, blistering or peeling skin, facial or tongue swelling, breathing difficulty, fainting, severe agitation, hallucinations, suicidal thoughts, or a severe psychiatric change. Serious skin reactions and severe hypersensitivity reactions are rare but can progress quickly. The FDA prescribing information describes these warnings for modafinil products [3].

How it affects the body

Modafinil changes activity in several wakefulness pathways. One recognised action is reduced dopamine reuptake, which increases dopamine signalling in selected areas of the brain. Dopamine is a chemical messenger involved in alertness, motivation, movement, and attention.

The full mechanism is more complex than a simple dopamine increase. Modafinil also influences other systems involved in the sleep-wake cycle, including networks that regulate wakefulness and attention. This may help reduce sleep attacks and improve the ability to remain awake during the day.

The result is increased alertness, not guaranteed cognitive enhancement. A person whose concentration has been impaired by severe sleepiness may feel mentally clearer once wakefulness improves. Someone who is already well rested may experience little useful benefit and may instead develop anxiety, headache, or trouble sleeping.

The European Medicines Agency has evaluated modafinil in relation to excessive sleepiness and associated safety concerns [2]. Clinical response can vary according to the underlying sleep disorder, sleep schedule, other medicines, and the timing of each dose.

If a dose is taken late in the day, the wakefulness effect may continue into the intended sleep period. Dose timing is one of the most common practical reasons for insomnia during treatment.

Common mistakes

Several practical mistakes can reduce benefit or increase risk:

  • Taking the tablet late because daytime sleepiness has already become severe.
  • Doubling the next dose after forgetting one.
  • Using Modalert to compensate for repeated short nights.
  • Treating ordinary tiredness without investigating sleep, mood, anaemia, thyroid disease, or other causes.
  • Combining it with amphetamine, armodafinil, high-caffeine products, or stimulant supplements without review.
  • Assuming that a higher strength will produce a better result.
  • Continuing to drive despite dizziness or blurred vision.
  • Stopping continuous positive airway pressure because wakefulness has improved.
  • Ignoring a rash because the initial symptoms seem mild.
  • Failing to mention hormonal contraception, warfarin, psychiatric medicines, or liver disease.

A tablet that improves alertness can create a false sense of recovery. The original sleep disorder still needs appropriate management.

Comparison

Alternatives and related wakefulness medicines

Generic modafinil products contain the same active ingredient category as Modalert. Armodafinil contains the R-enantiomer of modafinil, meaning one specific molecular form of the compound. Its duration and tolerability may differ between individuals.

Medicine category Pharmacological relationship Prescribing considerations
Modafinil tablets Contains modafinil Selection depends on diagnosis, timing, response, and adverse effects
Armodafinil medicines Contains the R-enantiomer of modafinil May have different duration and tolerability; switching requires assessment
Other wakefulness approaches May use a different mechanism Choice depends on the sleep disorder, cardiovascular status, mental health, and interactions

Products containing the same active ingredient should not be combined. Switching from modafinil to armodafinil also requires an individual plan because tablet strength, duration, and response are not interchangeable by simple name recognition.

Modalert compared with other stimulant medicines

A stimulant medicine increases activity in central nervous system pathways, while a wakefulness-promoting agent is selected more specifically for pathological sleepiness. The categories overlap, but they are not interchangeable.

Amphetamine-based medicines, including Adderall XR, have recognised effects on dopamine and noradrenaline and are used for selected conditions such as attention-deficit/hyperactivity disorder. Methylphenidate, the active ingredient in Ritalin, also affects dopamine and noradrenaline transport. Modafinil has a different pharmacological profile and is primarily associated with wakefulness disorders.

Armodafinil is closely related to modafinil. It is not the same as an amphetamine and should not be treated as a direct substitute without prescriber review.

Cardiovascular effects, anxiety, sleep disruption, misuse potential, psychiatric history, and prescribing controls influence the choice between these categories. A person with narcolepsy may need a different approach from someone with attention-deficit/hyperactivity disorder or treatment-resistant fatigue.

What doctors say

In clinical practice, doctors usually begin by confirming the cause of daytime sleepiness. A sleep diary, sleep history, shift pattern, blood pressure review, mental health assessment, and medicine review can reveal factors that Modalert alone cannot correct.

Treatment response is assessed through alertness, sleep attacks, work or driving safety, night-time sleep, anxiety, mood, blood pressure, and unwanted symptoms. Modalert can improve wakefulness without curing narcolepsy. Planned sleep and follow-up remain part of long-term management.

A practical record can include:

  • Dose time.
  • Bedtime and waking time.
  • Sleep attacks or unintended naps.
  • Alertness during work or driving.
  • Headache, nausea, anxiety, dizziness, or visual changes.
  • Blood pressure readings when monitoring has been advised.

One detail patients often miss is that improved alertness can hide accumulating sleep debt. Feeling awake after a short night does not prove that the brain has recovered. The World Health Organization's 2022 ICD-11 includes sleep-wake disorders, while medicine-specific decisions remain based on the diagnosed condition [4].

Approved indications, safety warnings, and prescribing rules can be updated. The current Medsafe information should be considered when treatment is initiated or changed.

Comparison

Armodafinil

Active ingredient: Armodafinil
150mg
From $ 122.20
pills
3.2 (3)

Modalert Current

Active ingredient: Modafinil
100mg 200mg
From $ 88.36
pills
3.9 (4)

Modvigil

Active ingredient: Modafinil
100mg 200mg
From $ 169.20
pills
3.3 (3)

Compare all medicines for Sleep Disorders

Common questions

What is the best time of day to take Modalert?

The best time depends on the diagnosis and the prescribed schedule. For daytime narcolepsy or sleepiness, the tablet is commonly taken early enough to support wakefulness without interfering with night sleep. For shift-work sleep disorder, the timing may be linked to the planned shift. Medsafe’s 2024 modafinil information supports individualised timing because insomnia is a recognised treatment concern [5]. A clinician can adjust timing if sleep becomes difficult.

How long does one dose of Modalert keep working?

A dose may support wakefulness for much of the planned waking period, but the duration varies with metabolism, liver function, sleep disorder, dose timing, and interacting medicines. The effect can persist into the night if the tablet is taken late. The response should be judged by alertness and sleep quality rather than by trying to extend the effect independently. The EMA’s 2010 safety information describes sleep disturbance as a clinically relevant concern with modafinil treatment.

Which diet, exercise, or habits help or hinder the result?

Regular sleep timing, planned naps when prescribed, moderate physical activity, and treatment of obstructive sleep apnoea can support the clinical goal. Repeated sleep restriction, irregular shift changes, heavy alcohol use, and late caffeine can worsen insomnia and daytime fatigue. Large changes in diet or supplements should be reported because some products can affect medicines or sleep. The World Health Organization's 2022 ICD-11 provides a clinical framework for sleep-wake disorders.

How should Modalert be stored at home and while travelling?

Keep the tablets in a dry place at ordinary room temperature, away from excess heat, moisture, and direct light. Store them securely and separately from medicines used by other people. During travel, keep the medicine with your essential medicines rather than in a hot vehicle or checked luggage. Medsafe’s 2024 information advises following the approved storage conditions for the specific medicine, and travel plans should also account for local controlled-medicine rules.

Can Modalert be used during pregnancy or breastfeeding?

Pregnancy requires medical review before treatment because modafinil exposure may carry risks to the developing baby. Breastfeeding also requires an individual decision about whether treatment should continue and how the infant will be monitored. Modafinil can reduce the reliability of hormonal contraception, which is relevant before conception and after treatment changes. The EMA’s 2010 safety assessment highlighted pregnancy prevention and contraception as important considerations for modafinil.

How soon can the effect of Modalert become noticeable?

Some people notice greater wakefulness on the first treatment day, while others need several days for the timing and regimen to be assessed. Early alertness does not confirm that the underlying sleep disorder is controlled. Headache, anxiety, or insomnia may also appear early and should be recorded. Clinical studies reviewed by the EMA in 2010 assessed response over treatment periods rather than treating a single day as proof of long-term benefit.

Can alcohol be used while taking Modalert?

Alcohol can worsen sleep quality, impair judgement, and make it harder to recognise whether dizziness, anxiety, or poor coordination is caused by treatment. Combining alcohol with a wakefulness-promoting medicine may also encourage a person to stay awake while still impaired. Avoid alcohol until the individual response is clear and follow the prescriber’s specific advice. Medsafe’s 2024 safety information supports caution with activities requiring alertness when adverse effects or impairment may occur.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Sources

  1. Medsafe (2024). Data Sheet and Consumer Medicine Information for modafinil-containing medicines.
  2. European Medicines Agency (2010). Assessment report for modafinil-containing medicinal products.
  3. U.S. Food and Drug Administration (2023). Provigil (modafinil) Prescribing Information.
  4. World Health Organization (2022). ICD-11 for Mortality and Morbidity Statistics: Sleep-wake disorders.
  5. European Medicines Agency (2010). Referral assessment: modafinil and the risk of serious psychiatric, cardiovascular, and pregnancy-related adverse effects.

Reviews: Modalert

3.9
Based on 4 reviews
Luke, 38 Masterton Three months
Verified
Rating: 4 out of 5

The first week brought headaches and a wired feeling. Those settled, and I had fewer unplanned naps by the fourth week. Taking it after lunch was a mistake because I was awake much later.

19 Oct 2026
Stephen, 34 New Plymouth Six weeks
Verified
Rating: 3.5 out of 5

It helped during the hardest part of the night shift, especially when my sleep schedule was stable. I still felt tired after several poor nights, and increasing the amount was not the answer.

27 Oct 2026
Liam, 59 Nelson Several weeks
Verified
Rating: 5 out of 5

My daytime alertness improved, but I continued using my prescribed airway treatment. I noticed dry mouth and mild nausea at first, which became less troublesome after the timing was adjusted.

5 Nov 2026
Ian, 57 Te Awamutu Several weeks
Verified
Rating: 3 out of 5

The alertness was noticeable, but the visual symptoms made driving uncomfortable. I stopped driving and contacted the clinic rather than taking another tablet.

14 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 361 reviews Install